GLP1R and diabetes mellitus: In addition, in CRTd patients with diabetes the GLP-1 RA therapy vs. controls reduced the number of ATP events (37 vs. 68, p value < 0.05), the number of ICD shocks (9 vs. 43, p value < 0.05) and the number of inappropriate therapy events (12 vs. 21, p value < 0.05), with an increased number of appropriate therapy events (74 vs. 38, p value < 0.05).